BioSante presents vaccine report
LINCOLNSHIRE - BioSante Pharmaceuticals Inc. will present a BioSante cancer vaccine portfolio update at the BIO International Convention, which will take place May 3-6 in Chicago. Stephen M. Simes, BioSante's president and CEO, will provide a status report on BioSante's portfolio of cancer vaccines in clinical development, as well as an update on LibiGel testosterone gel in clinical development for the treatment of female sexual dysfunction.